2018
DOI: 10.1101/274472
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood

Abstract: Understanding the difference in genetic regulation of gene expression between brain and blood is important for discovering genes associated with brain-related traits and disorders. Here, we estimate the correlation of genetic effects at the top associated cis-expression (cis-eQTLs or cis-mQTLs) between brain and blood for genes expressed (or CpG sites methylated) in both tissues, while accounting for errors in their estimated effects (rb). Using publicly available data (n = 72 to 1,366), we find that the genet… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

6
93
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 68 publications
(99 citation statements)
references
References 62 publications
6
93
0
Order By: Relevance
“…The SMR software was used and analysis was performed for each individual disorder as well as using results from our GWAS metaanalyses (48). We used GWAS summary statistics for each studied disorder (as described above), the LD structure from from 1000 Genomes European reference panel and summary statistics from brain expression quantitative trait loci (eQTL) analysis (49), which quantified the effect of SNPs over gene expression levels in brain tissue (36,50). Only variants showing a consistent allele frequency (pairwise MAF difference between datasets no more than 0.20) across all three datasets (GWAS summary statistic, 1000 Genome reference, and eQTL summary statistic) were included in the analysis.…”
Section: Transcriptome-wide Association Studymentioning
confidence: 99%
“…The SMR software was used and analysis was performed for each individual disorder as well as using results from our GWAS metaanalyses (48). We used GWAS summary statistics for each studied disorder (as described above), the LD structure from from 1000 Genomes European reference panel and summary statistics from brain expression quantitative trait loci (eQTL) analysis (49), which quantified the effect of SNPs over gene expression levels in brain tissue (36,50). Only variants showing a consistent allele frequency (pairwise MAF difference between datasets no more than 0.20) across all three datasets (GWAS summary statistic, 1000 Genome reference, and eQTL summary statistic) were included in the analysis.…”
Section: Transcriptome-wide Association Studymentioning
confidence: 99%
“…Querying these three variants for eQTL status in the GTEx data (version 7) [25] revealed DENND1B (rs12740041), TTC33 (rs4957144) and PSMF1 (rs116843836) as potential target genes in various tissues ( Table 2). Additional scan of blood (N > 30,000) [26] and brain (N > 520) [27] eQTL summary statistics with substantially larger sample sizes than corresponding tissues in GTEx (Nblood<400, Nbrain<200) suggested rs12740041 as eQTL for DENND1B and rs4957144 as eQTL from TTC33 in both blood and brain, while rs4957144 was also highlighted as potential eQTL for RPL37 gene in brain ( Table 2). TTC33 is 158 kb downstream of rs4957144 ( Supplementary Figure 3), thus is not shown in Table 1, however, we decided to include it into consequent analyses together with genes listed in Table 1.…”
Section: Functional Annotation Of Identified Locimentioning
confidence: 99%
“…Additionally, eQTL status for lead variants identified in the conjFDR analysis was checked in brain eQTL summary statistics extracted from [27] and blood eQTL summary statistics from [26]. LocusCompare tool (see URLs) was then applied to check whether loci identified in conjFDR analysis colocalizes with eQTL signal.…”
Section: Functional Mapping and Annotation Of Identified Locimentioning
confidence: 99%
See 2 more Smart Citations